164 related articles for article (PubMed ID: 2537759)
1. Inhibition of dihydropyridine-sensitive calcium channels by the plant alkaloid ryanodine.
Valdivia HH; Coronado R
FEBS Lett; 1989 Feb; 244(2):333-7. PubMed ID: 2537759
[TBL] [Abstract][Full Text] [Related]
2. [3H]PN200-110 and [3H]ryanodine binding and reconstitution of ion channel activity with skeletal muscle membranes.
Hamilton SL; Alvarez RM; Fill M; Hawkes MJ; Brush KL; Schilling WP; Stefani E
Anal Biochem; 1989 Nov; 183(1):31-41. PubMed ID: 2559627
[TBL] [Abstract][Full Text] [Related]
3. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
5. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
6. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of calcium channels from a purified dihydropyridine receptor preparation.
Talvenheimo JA; Worley JF; Nelson MT
Biophys J; 1987 Nov; 52(5):891-9. PubMed ID: 2447966
[TBL] [Abstract][Full Text] [Related]
8. Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptors.
el-Hayek R; Parness J; Valdivia HH; Coronado R; Hogan K
Biochem Biophys Res Commun; 1992 Sep; 187(2):894-900. PubMed ID: 1326958
[TBL] [Abstract][Full Text] [Related]
9. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
10. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
Feron O; Wibo M; Christen MO; Godfraind T
Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
[TBL] [Abstract][Full Text] [Related]
11. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
[TBL] [Abstract][Full Text] [Related]
12. Ratio of dihydropyridine to ryanodine receptors in mammalian and frog twitch muscles in relation to the mechanical hypothesis of excitation-contraction coupling.
Margreth A; Damiani E; Tobaldin G
Biochem Biophys Res Commun; 1993 Dec; 197(3):1303-11. PubMed ID: 8280147
[TBL] [Abstract][Full Text] [Related]
13. Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum.
Valdivia HH; Valdivia C; Ma J; Coronado R
Biophys J; 1990 Aug; 58(2):471-81. PubMed ID: 2169916
[TBL] [Abstract][Full Text] [Related]
14. Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle.
Valdivia HH; Coronado R
J Gen Physiol; 1990 Jan; 95(1):1-27. PubMed ID: 2153750
[TBL] [Abstract][Full Text] [Related]
15. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
Borsotto M; Barhanin J; Norman RI; Lazdunski M
Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
[TBL] [Abstract][Full Text] [Related]
16. Effects of perchlorate on the molecules of excitation-contraction coupling of skeletal and cardiac muscle.
Ma J; Anderson K; Shirokov R; Levis R; González A; Karhanek M; Hosey MM; Meissner G; Ríos E
J Gen Physiol; 1993 Sep; 102(3):423-48. PubMed ID: 8245818
[TBL] [Abstract][Full Text] [Related]
17. High-affinity [3H]PN200-110 and [3H]ryanodine binding to rabbit and frog skeletal muscle.
Anderson K; Cohn AH; Meissner G
Am J Physiol; 1994 Feb; 266(2 Pt 1):C462-6. PubMed ID: 8141261
[TBL] [Abstract][Full Text] [Related]
18. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
Chu A; Díaz-Muñoz M; Hawkes MJ; Brush K; Hamilton SL
Mol Pharmacol; 1990 May; 37(5):735-41. PubMed ID: 1692609
[TBL] [Abstract][Full Text] [Related]
19. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
[TBL] [Abstract][Full Text] [Related]
20. Postnatal maturation of excitation-contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1,4-dihydropyridine and ryanodine receptors.
Wibo M; Bravo G; Godfraind T
Circ Res; 1991 Mar; 68(3):662-73. PubMed ID: 1660357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
